CD4+CD25+LAP+ T cells have been shown to participate in the control of intestinal inflammation in experimental models of colitis [39] and CD4+LAP+ T cells, either expressing CD25 or not, have recently been reported as a distinct subset of T cells [40]. This evidence concerns the gene TGFB1 and colitis.